Company intelligence / Profile preview
Shanghai First Song Therapeutics
Shanghai, Shanghai Shi, Chinapharmaceutical-technology.com ↗
- Ownership
- Private
- Development stage
- Phase 1
01
Overview
Shanghai First Song Therapeutics is an innovative Chinese biotechnology company focused on developing, manufacturing, and commercializing autologous and dual-targeting chimeric antigen receptor T-cell (CAR-T) immunotherapies. The company has several active clinical-stage programs targeting both solid tumors and hematological malignancies. Its lead assets are in Phase I trials for indications such as gastric, colorectal, breast, pancreatic, esophageal cancers and lymphoma. Early results from ongoing studies are not yet published in detail.
- Therapeutic areas
- OncologyRheumatologyImmunology
- Modalities
- Autologous CAR-T cell therapiesGene therapiesImmunotherapies
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on Shanghai First Song Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shanghai First Song Therapeutics.